A new approach for pharmacokinetics of single-dose cetuximab in rhesus monkeys by surface plasmon resonance biosensor

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 2, 2009, Pages 183-188

  Che, Jinjing ^a   Wang, Hui ^a   Chen, Zhihang ^a   Li, Xin ^b   Hou, Yunan ^a   Shan, Chengqi ^a   Cheng, Yuanguo ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Biacore; Cetuximab; EGFR; Pharmacokinetics; Surface plasmon resonance

Indexed keywords

CD20 ANTIBODY; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; IMMOBILIZATION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OPTICAL BIOSENSOR; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHESUS MONKEY; ROOM TEMPERATURE; SURFACE PLASMON RESONANCE; VALIDATION STUDY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BIOSENSING TECHNIQUES; HALF-LIFE; MACACA MULATTA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 66049088415     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.04.009     Document Type: Article

References (29)

1. Saba N.F., and Khuri F.R. Oncology (Williston Park) 20 (2006) 153-161
2. Ciardiello F. Future Oncol. 1 (2005) 221-234
3. Prewett M., Ockwell P., Rockwell R.F., et al. J. Immunother. Emphasis Tumor Immunol. 19 (1996) 419-427
4. Waksal H.W. Cancer Metastasis Rev. 18 (1999) 427-436
5. Prewett M., Rothman M., Waksal H., et al. Clin. Cancer Res. 4 (1998) 2957-2966
6. Bartlett J.M., Langdon S.P., Simpson B.J., et al. Br. J. Cancer 73 (1996) 301-306
7. Fischer C.J., Witt A., Heinzl H., et al. Anticancer Res. 17 (1997) 613-619
8. Ilekis J.V., Connor J.P., Prins G.S., et al. Gynecol. Oncol. 66 (1997) 250-254
9. Ciardiello F., and Tortora G. Clin. Cancer Res. 7 (2001) 2958-2970
10. Mendelsohn J. J. Clin. Oncol. 20 (2002) 1S-13S
11. Schilder R.J., Sill M.W., Chen X.W., et al. Clin. Cancer Res. 11 (2005) 5539-5548
12. Goldstein N.I., Prewett M., Zuklys K., et al. Clin. Cancer Res. 1 (1995) 1311-1318
13. Fan Z., Baselga J., and Masui H. Cancer Res. 53 (1993) 4637-4642
14. Balin D., and Delord J.P. Cancer Chemother. Pharmacol. 57 (2006) 709-718
15. Sung F.L., Poon T.C.W., Hui E.P., et al. In Vivo 19 (2005) 237-245
16. Herbst R.S., and Arquette M. J. Clin. Oncol. 23 (2005) 5578-5587
17. Burtness B., and Goldwasser M.A. J. Clin. Oncol. 23 (2005) 8646-8654
18. Cunningham D., Humblet Y., Siena S., et al. N. Engl. J. Med. 351 (2004) 337-345
19. Humblet Y., Peeters M., Gelderblom H., et al. Eur. J. Cancer Suppl. 5 (2007) 240
20. Ciardiello F., Cervantes A., and Vega-Villegas M. Eur. J. Cancer Suppl. 5 (2007) 247
21. Catherine D., Jean-Yves P., and Véronique D. Eur. J. Cancer 41 (2005) 1739-1745
22. Delbaldo C., Pierga J.Y., and Dieras V. Eur. J. Cancer Suppl. 1 (2003) S167
23. S. Hashimoto, Principles of BIAcore, Tokyo, 2000, p25-p26.
24. Baxter A., Ferguson J.P., O'Connor M.C., et al. J. Agric. Food Chem. 49 (2001) 3204-3207
25. Marianne C., Saral S., and Joanna D. J. Agric. Food Chem. 53 (2005) 7367-7370
26. Gillis E.H., Gosling J.P., and Sreenan J.M. J. Immunol. Method 267 (2002) 131-138
27. Skottrup P., Stephen H., and Hanne F. Biosens. Bioelectron. 22 (2007) 2724-2729
28. Kikuchi Y., Uno S., Nanami M., et al. J. Biosci. Bioeng. 100 (2005) 311-317
29. USFDA, 2001, http://www.fda.gov/cder/guidance/4252fnl.htm.